Stay updated on Olaparib Plus Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the Olaparib Plus Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Olaparib Plus Pembrolizumab Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The revision label on the page was updated from v3.4.1 to v3.4.2.
    Difference
    0.0%
    Check dated 2026-02-12T02:11:03.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision: v3.4.1 replaces v3.4.0, a minor update with no changes to study data or visible page content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-04T22:58:21.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option, implemented green/red highlights for additions/deletions, and updated the footer with Revision: v3.4.0; removed the old 'No FEAR Act data' entry and the v3.3.4 label.
    Difference
    0.3%
    Check dated 2026-01-28T20:25:28.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Footer now displays Revision: v3.3.4; the previous Revision: v3.3.3 entry was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T04:00:29.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added Revision: v3.3.3; removed HHS Vulnerability Disclosure and Revision: v3.3.2.
    Difference
    0.1%
    Check dated 2025-12-23T21:50:45.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added to the page. Revision: v3.2.0 was removed.
    Difference
    0.0%
    Check dated 2025-11-25T11:01:02.000Z thumbnail image

Stay in the know with updates to Olaparib Plus Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Olaparib Plus Pembrolizumab Clinical Trial page.